MarketFoolery

Shares of Universal Display pop on news that Apple may be going with OLED screens on all of its 2019 iPhone models. Jason Moser analyzes the perils and promise of being a key supplier for the world’s biggest public company. We also discuss Disney potentially adding cash to outbid Comcast for Fox’s assets, as well as Coca-Cola selling the first alcoholic beverage in company history.

Best Buy’s 1st-quarter same-store sales crushed expectations. So why is the stock dropping? Matt Argersinger analyzes Best Buy’s upcoming fiscal year and shares why consumer electronics might be on shaky ground. Plus, we discuss a potential catalyst for Chinese stocks and dip into the Fool Mailbag for a great question on valuation. Thanks to Harry’s for supporting The Motley Fool.  Get your Trial Set – go to Harrys.com/Fool

Lowe’s 1st-quarter sales came in light, but shares still rose 10%. Did the announcement of a new CEO top Lowe’s actual performance? Abi Malin analyzes the results, as well as Target’s 1st-quarter miss and Tiffany’s new all-time high.

Have you seen the latest drama at CBS?  It’s not on the network, it’s in the board room. Investor-At-Large Tim Hanson analyzes the battle for the future of CBS. Plus, he shares why he’s watching the increasingly fragmented world of retail and why companies like Shopify and Square could be among the big winners.

Thanks to Harry’s for supporting The Motley Fool.  Get your Trial Set – go to Harrys.com/Fool

Though currently littered with penny stocks, the landscape for investing in marijuana is improving.  Shannon Jones analyzes the recent merger of Aurora Cannabis and MedReleaf, and the impending FDA approval for GW Pharmaceuticals.  Plus, we discuss how professional athletes and owners are helping the case by becoming more vocal about marijuana as a device for pain management.